Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb Pharmaceuticals Group

Executive Summary

President-Central and Eastern Europe Joachim von Roy named president-Europe. He will continue to be based in Munich, reporting to Pharmaceutical Group President Kenneth Weg. In addition, von Roy assumes worldwide responsibility for BMS' cardiovascular product planning and becomes a member of group's operating committee. Samuel Hamad, president of the intercontinental division of the BMS Pharmaceutical Group, has assumed responsibility for Latin America and Japan in addition to his current responsibilities of Asia, Australia/New Zealand, Canada, the Middle East and Africa.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS022416

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel